11 Unstoppable Growth Stocks to Invest in Now
BlackRock highlighted that the trade conflict between the US and China continues to cause major economic disruptions.
Posts Tagged ‘NASDAQ:XERS’
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2025 Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2025 Earnings Call Transcript May 8, 2025Xeris Biopharma Holdings, Inc. beats earnings expectations.
10 Best Multibagger Penny Stocks to Buy According to Billionaires
Penny stocks always seem like bargains for gaining exposure to some of the fastest-growing segments or spectacles, especially when popular stocks cost hundreds or thousands of...
10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
12 Best Stocks to Invest in for a Stock Market Game
We all have heard the phrase ‘value isn’t always visible at first glance’ at least once in our lifetime and this isn’t something to overlook, particularly when you are...
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2024 Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2024 Earnings Call Transcript March 6, 2025Xeris Biopharma Holdings, Inc. beats earnings expectations.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2024 Earnings Call Transcript November 8, 2024Xeris Biopharma Holdings, Inc. beats earnings expectations.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2024 Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2024 Earnings Call Transcript August 8, 2024Xeris Biopharma Holdings, Inc. beats earnings expectations.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q1 2024 Earnings Call Transcript
Operator: Hello, everyone, and welcome to the Xeris Biopharma First Quarter 2024 Financial Results Conference Call and Webcast.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
Operator: Hello everyone and welcome to the Xeris fourth quarter and full year 2023 financial results conference call and webcast.
5 High Growth Micro-cap Stocks to Buy
In this article, we discuss 5 high-growth micro-cap stocks to buy.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q3 2023 Earnings Call Transcript
Operator: Hello, everyone and welcome to the Xeris Biopharma Third Quarter 2023 Financial Results Call. My name is Bruno. I'll be operating your call today.
10 Best Fast Growing Penny Stocks to Buy Now
In this article, we will take a look at the 10 best fast growing penny stocks to buy now.
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q2 2023 Earnings Call Transcript
Operator: Good morning all. I would like to welcome you all to Xeris Biopharma Second Quarter 2023 Financial Results Call.
10 Best Medical Stocks Under $5
In this piece, we will take a look at the ten best medical stocks under $5.
Hedge Funds Are Selling Xeris Pharmaceuticals, Inc. (XERS)
We at Insider Monkey have gone over 873 13F filings that hedge funds and prominent investors are required to file by the SEC.
Is XERS A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think Xeris Pharmaceuticals, Inc. (NASDAQ:XERS) is a good investment right now.
Hedge Funds Are Crazy About Xeris Pharmaceuticals, Inc. (XERS)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Hedge Funds Have Never Been This Bullish On Xeris Pharmaceuticals, Inc. (XERS)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Selling Xeris Pharmaceuticals, Inc. (XERS)
A whopping number of 13F filings filed with U.S.
Is Xeris Pharmaceuticals, Inc. (XERS) A Good Stock To Buy?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Hedge Fund and Insider Trading News: Ray Dalio, Nelson Peltz, Weight Watchers International, Inc. (WTW), Xeris Pharmaceuticals Inc (XERS), Carolina Financial Corporation (CARO), and More
Hedge fund legend Ray Dalio, who runs Bridgewater Associates, is widely considered to be one of the most successful hedge fund managers in the world.
Hedge Fund and Insider Trading News: Carl Icahn, SkyBridge Capital, Xeris Pharmaceuticals Inc (XERS), Legacy Reserves LP Unit (LGCY), Pershing Gold Corp (PGLC), and More
(Reuters) - Activist investor Carl Icahn boosted his stake in Energen Corp (EGN.N), a filing showed on Tuesday, as he eyes a potential takeover of the oil and gas producer.
